Resistance of t(17;19)‐acute lymphoblastic leukemia cell lines to multiagents in induction therapy
Atsushi Watanabe(National University of Singapore), Kanji Sugita(University of Yamanashi), Masayoshi Minegishi, Akira Ohara(Toho University), Masatoshi Takagi(Tokyo Medical and Dental University), Toshiya Inaba(Hiroshima University), Masako Abe(University of Yamanashi Hospital), Takeshi Inukai(University of Yamanashi), Hiroaki Goto(Yokohama City University), Toru Nanmoku(University of Tsukuba Hospital), Hiroko Fukushima(University of Tsukuba Hospital), Thomas Look(University of Zurich), Hiroko Oshiro(University of Yamanashi), Mark P. Kamps(University of California San Diego), Shinpei Somazu(University of Yamanashi), Daisuke Harama(University of Yamanashi), Etsuro Ito(Okayama University), Tsutomu Toki(Hirosaki University), Koshi Akahane(University of Yamanashi), Junko Takita(Kyoto University), Tatsuya Ito(Hirosaki University), Hiroyuki Takahashi(Children's Cancer Association of Japan), Takashi Fukushima(University of Tsukuba), Tamao Shinohara, Mikiya Endo(Iwate Medical University), Keiko Kagami(University of Yamanashi), Kumiko Goi(St. Jude Children's Research Hospital), Junya Fujimura(Kagawa Prefectural Central Hospital), Kiminori Terui(Hirosaki University)
Cited by 22
Related Papers
Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases
|Proceedings of the National Academy of Sciences|2018|324
Fusion of the Leucine Zipper Gene <i>HLF</i> to the <i>E2A</i> Gene in Human Acute B-Lineage Leukemia
|Science|1992|298
Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2012|296